Molecular and clinical characteristics of MSH6 germline variants detected in colorectal cancer patients
- 2 October 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (6), 2909-2916
- https://doi.org/10.3892/or.2013.2781
Abstract
The MSH6 gene is one of the mismatch repair genes involved in Lynch syndrome and its mutations account for 10-20% of Lynch syndrome. Although previous studies suggested that the difference of the geographical region affects the clinical phenotype of Lynch syndrome, there has been no report on the detailed features of Japanese Lynch syndrome patients carrying an MSH6 mutation. The aim of the present study was to investigate the clinical and molecular features of MSH6 mutation carriers in Japan. Surgically resected 1720 colorectal carcinoma specimens were screened by microsatellite instability (MSI) testing and the MSI-high cases were subjected to a germline mutation analysis of the mismatch repair genes MLH1, MSH2 and MSH6. We investigated the clinical and molecular features of the MSH6 variants, such as the family cancer history, pathological findings, immunohistochemistry, methylation status of the MLH1 promoter and BRAF mutation in the colorectal tumor. Furthermore, the impact of the missense variants on MSH6 protein was predicted by using in silico tools. We identified nine novel pathogenic mutations and eight unclassified missense variants. Among the eight missense variants, three were suspected pathogenic by in silico analysis. We also found that most colorectal cancers in the MSH6 mutation carrier were diagnosed after the age of 50 and were localized distally. Furthermore, the mean age at diagnosis of endometrial cancer in Japanese MSH6 mutation carriers (49.2 years) was earlier than previous reports from Western countries (56.5 years). These results may improve the surveillance program for Japanese MSH6 mutation carriers.Keywords
This publication has 34 references indexed in Scilit:
- CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the proteinJournal of Biomedical Science, 2013
- Risks of Less Common Cancers in Proven Mutation Carriers With Lynch SyndromeJournal of Clinical Oncology, 2012
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Risks of Lynch Syndrome Cancers for MSH6 Mutation CarriersJNCI Journal of the National Cancer Institute, 2010
- Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal CancerJournal of Clinical Oncology, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factorsGut, 2008
- Functional Characterization of Pathogenic Human MSH2 Missense Mutations in Saccharomyces cerevisiaeGenetics, 2007
- Characterization of a novel oncogenic K-ras mutation in colon cancerBiochemical and Biophysical Research Communications, 2007
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991